A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer

TerminatedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

January 18, 2023

Primary Completion Date

June 16, 2023

Study Completion Date

June 16, 2023

Conditions
Bladder Cancer
Interventions
DRUG

Avelumab

As used in real world practice

Trial Locations (7)

1426ANZ

Alexander Fleming S.A (Instituto Medico Especializado Alexander Fleming), Ciudad Autonoma de Buenos Aires

B1900AXI

Comite de Etica de la Investigacion del Hospital Italiano de La Plata, La Plata

X5000BSQ

Sanatorio Privado de la Cañada, Córdoba

90035-001

Hospital Moinhos de Vento, Porto Alegre

90110-270

Hospital Mãe de Deus/Aesc, Porto Alegre

Unknown

Hospital Alemão Oswaldo Cruz, São Paulo

22250-950

Oncoclínicas Do Brasil Servicos Médicos S/A - Oncocentro, Rio de Janeiro

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT05568407 - A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer | Biotech Hunter | Biotech Hunter